Pharmexcil urges balance between compliance and commerce to safeguard India’s export momentum and ‘Pharmacy of the World’ status Read more
Pharmexcil reports robust exports: $ 2,475.70 mn in May 2025, Cumulating to $ 4,961.71 mn for April-May FY26 Read more
PharmaLytica 2024: charting India’s pharma’s path to USD 130 billion by 2030 from the powerhouse hub of Hyderabad Read more